An employee error at a Johnson & Johnson plant in the U.S. state of Maryland led to the loss of 15 million doses of coronavirus vaccine, The New York Times reported Wednesday, March 31.
The incident occurred at the Baltimore plant, with workers making an error in mixing the drug’s ingredients. After the incident, the U.S. Food and Drug Administration (FDA) began an inspection of the plant.
It is noted that all batches of the company’s vaccine, which have already arrived in the U.S. hospitals, are safe because they were produced in the Netherlands. Subsequent batches of the drug were planned to be sent from the plant in Baltimore, but FDA inspections will lead to delays in deliveries due to downtime.
Earlier Wednesday, it was reported that a 74-year-old man in Virginia had a rash on his body after being vaccinated with Johnson & Johnson, after which his skin began to peel off.
On March 17, a World Health Organization (WHO) strategic advisory panel of immunization experts recommended that possible side effects from the Johnson & Johnson vaccine, including allergies and blood clotting problems, be closely monitored.
On March 12, WHO placed the COVID-19 vaccine from Janssen’s Johnson & Johnson pharmaceutical division on its list of recommended emergency uses.